XML 39 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment and Geographic Data Information
12 Months Ended
Dec. 31, 2011
Description of Business Segments  
Description of Business Segments
Business Segment and Geographic Data Information
We are organized into operating segments based on product groupings. These operating segments have been aggregated into four reportable global business segments: Personal Care, Consumer Tissue, KCP & Other, and Health Care. The reportable segments were determined in accordance with how our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other (income) and expense, net and income and expense not associated with the business segments, including the charges related to the pulp and tissue restructuring described in Note 2.

The principal sources of revenue in each global business segment are described below:

•
Personal Care brands offer parents a trusted partner in caring for their families and deliver confidence, protection and discretion to adults, through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, Poise and other brand names.

•
Consumer Tissue offers a wide variety of innovative solutions and trusted brands that touch and improve people's lives every day.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other brand names.

•
K-C Professional & Other helps transform workplaces for employees and patrons, making them healthier, safer, and more productive, through a range of solutions and supporting products such as apparel, wipers, soaps, sanitizers, tissues, and towels.  Key brands in this segment include: Kleenex, Scott, WypAll, Kimtech, and Jackson Safety. 

•
Health Care provides the essentials that help restore patients to better health and improve the quality of patients' lives. Through a portfolio of innovative medical device and infection prevention products, Health Care offers clinicians a range of solutions in pain management, respiratory and digestive health and medical supplies for the operating room. This business is a global leader in education to prevent healthcare-associated infections. Products are sold primarily under the Kimberly-Clark and ON-Q brand names.

Net sales to Wal-Mart Stores, Inc. were approximately 12 percent in 2011, and 13 percent in both 2010 and 2009.
Information concerning consolidated operations by business segment and geographic area, as well as data for equity companies, is presented in the following tables:

Consolidated Operations by Business Segment
 
Personal
Care
 
Consumer
Tissue
 
K-C
Professional
& Other
 
Health
Care
 
Corporate
& Other
 
Consolidated
Total
 
(Millions of dollars)
Net Sales
 
 
 
 
 
 
 
 
 
 
 
2011
$
9,128

 
$
6,770

 
$
3,294

 
$
1,606

 
$
48

  
$
20,846

2010
8,670

 
6,497

 
3,110

 
1,460

 
9

  
19,746

2009
8,365

 
6,409

 
3,007

 
1,371

 
(37
)
 
19,115

Operating Profit (a)
 
 
 
 
 
 
 
 
 
 
 
2011
1,526

 
775

 
487

 
219

 
(565
)
(b) 
2,442

2010
1,764

 
660

 
468

 
174

 
(293
)
(c) 
2,773

2009
1,739

 
736

 
464

 
244

 
(358
)
 
2,825

Depreciation and Amortization
 
 
 
 
 
 
 
 
 
 
 
2011
296

 
541

 
187

 
55

 
12

  
1,091

2010
277

 
329

 
142

 
56

 
9

  
813

2009
255

 
314

 
148

 
50

 
16

  
783

Assets
 
 
 
 
 
 
 
 
 
 
 
2011
6,582

 
5,685

 
2,783

 
2,529

 
1,794

  
19,373

2010
6,316

 
6,106

 
2,962

 
2,410

 
2,070

  
19,864

2009
5,895

 
5,871

 
2,969

 
2,558

 
1,916

  
19,209

Capital Spending
 
 
 
 
 
 
 
 
 
 
 
2011
543

 
255

 
114

 
53

 
3

  
968

2010
436

 
331

 
156

 
40

 
1

  
964

2009
440

 
271

 
97

 
38

 
2

  
848

(a)
Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.
(b)
Pulp and tissue restructuring charges of $415 million and a non-deductible business tax charge of $32 million related to a law change in Colombia are included in Corporate & Other in 2011. See additional information related to the pulp and tissue restructuring in Note 2. The restructuring charges related to the business segments are as follows:
 
Year Ended
December 31, 2011
 
(Millions of dollars)
Consumer Tissue
$
357

K-C Professional & Other
56

Other (income) and expense, net
2

Total
$
415


(c)
Included in Corporate & Other in 2010 is a $98 million charge related to the adoption of highly inflationary accounting in Venezuela effective January 1, 2010. See additional information in Note 3. The charges related to the business segments are as follows:
 
Year Ended
December 31, 2010
 
(Millions of dollars)
Personal Care
$
11

Consumer Tissue
6

K-C Professional & Other
2

Other (income) and expense, net
79

Total
$
98


Sales of Principal Products
 
2011
 
2010
 
2009
 
(Billions of dollars)
Consumer tissue products
$
6.7

 
$
6.4

 
$
6.3

Diapers
4.9

 
4.7

 
4.7

Away-from-home professional products
3.3

 
3.0

 
2.9

All other
5.9

 
5.6

 
5.2

Consolidated
$
20.8

 
$
19.7

 
$
19.1



Consolidated Operations by Geographic Area
 
United
States
 
Canada
 
Inter-
geographic
Items(a)
 
Total
North
America
 
Europe
 
Asia,
Latin
America
& Other
 
Inter-
geographic
Items
 
Corporate
& Other
 
Consolidated
Total
 
(Millions of dollars)
Net Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011
$
10,463

 
$
726

 
$
(443
)
 
$
10,746

 
$
3,401

 
$
7,467

 
$
(768
)
 
$
—

  
$
20,846

2010
10,480

 
684

 
(445
)
 
10,719

 
3,179

 
6,561

 
(713
)
 
—

  
19,746

2009
10,146

 
596

 
(322
)
 
10,420

 
3,220

 
6,124

 
(649
)
 
—

  
19,115

Operating Profit(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011
1,754

 
161

 
—

 
1,915

 
170

 
922

 
—

 
(565
)
 
2,442

2010
1,901

 
125

 
—

 
2,026

 
222

 
818

 
—

 
(293
)
 
2,773

2009
2,059

 
113

 
—

 
2,172

 
171

 
840

 
—

 
(358
)
 
2,825

Net Property
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011
4,124

 
28

 
—

 
4,152

 
1,439

 
2,458

 
—

 
—

  
8,049

2010
4,290

 
30

 
—

 
4,320

 
1,552

 
2,484

 
—

 
—

  
8,356

2009
4,174

 
32

 
—

 
4,206

 
1,582

 
2,245

 
—

 
—

  
8,033


(a)
Intergeographic net sales include $89 million, $95 million and $82 million by operations in Canada to the U.S. in 2011, 2010 and 2009, respectively.
(b)
Geographic operating profit excludes Other (income) and expense, net and income and expenses not associated with geographic areas.

Equity Companies’ Data
 
Net
Sales
 
Gross
Profit
 
Operating
Profit
 
Net
Income
 
Corporation’s
Share of Net
Income
 
(Millions of dollars)
2011
$
2,446

 
$
796

 
$
514

 
$
335

 
$
161

2010
2,310

 
815

 
555

 
378

 
181

2009
2,033

 
740

 
505

 
341

 
164

 
Current
Assets
 
Non-
Current
Assets
 
Current
Liabilities
 
Non-
Current
Liabilities
 
Stockholders’
Equity
 
(Millions of dollars)
2011
$
1,000

 
$
906

 
$
491

 
$
872

 
$
543

2010
1,198

 
919

 
520

 
982

 
615

2009
1,108

 
867

 
772

 
624

 
579



Equity companies are principally engaged in operations in the Personal Care and Consumer Tissue businesses, and amounts above primarily reflect operations in Latin America.
At December 31, 2011, our equity companies and ownership interest were as follows: Kimberly-Clark Lever Private Limited (India) (50%), Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries (47.9%), Olayan Kimberly-Clark Arabia (49%), Olayan Kimberly-Clark (Bahrain) WLL (49%) and Tecnosur S.A. (Colombia) (50%).

Kimberly-Clark de Mexico, S.A.B. de C.V. is partially owned by the public and its stock is publicly traded in Mexico. At December 31, 2011, our investment in this equity company was $239 million, and the estimated fair value of the investment was $2.7 billion based on the market price of publicly traded shares.